Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Masked divergence in cancer mortality following COVID-19 disruption.
Journal: Cancer epidemiology
Published: April 24, 2026
Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma.
Journal: Haematologica
Published: March 31, 2026
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.
Journal: Current oncology (Toronto, Ont.)
Published: March 09, 2026
Resistance to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma: Biology, Clinical Patterns, and Strategies to Overcome Treatment Failure.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 05, 2026
Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019-2023).
Journal: Frontiers in oncology
Published: January 18, 2026
G-CSF Timing After CAR-T: Early, Late - or Just Irrelevant?
Journal: Transplantation and cellular therapy
Published: January 18, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC Group.
Journal: Cancers
Published: December 12, 2025
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.
Journal: Blood cancer journal
Published: December 04, 2025
Response to letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 13, 2025
Last Updated: 09/26/2026